Translational Utility of Tumor-Derived FGF19 in a Novel Blood-Based Endocrine Suppression Approach
University of Central Florida
Summary
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Description
This project seeks to develop and test a more convenient detection modality for colorectal cancer and to test feasibility for breast cancer screening through a blood based test for cancer detection. Because detection of cancer is a fundamental need to facilitate treatment and decrease patient mortality, the ultimate objective of this proposal is to test applicability and context for the blood test, especially for patients that either are not eligible or do not want to participate in currently approved screening protocols. Colonoscopy and mammograms are gold standard cancer screening modalitie…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * The study will enroll adult persons with breast cancer or colorectal cancer or no cancer (healthy controls) who are able to do a fasting blood draw. (Pregnant women may choose to be in the study. The study procedures do not pose a risk to the safety of the unborn child or the woman.) Exclusion Criteria: * The study will not enroll persons who are unable or unwilling to provide informed consent. * Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.
Location
- Burnett School Biomedical SciencesOrlando, Florida